全文获取类型
收费全文 | 7905篇 |
免费 | 431篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 297篇 |
妇产科学 | 233篇 |
基础医学 | 810篇 |
口腔科学 | 145篇 |
临床医学 | 1367篇 |
内科学 | 1226篇 |
皮肤病学 | 76篇 |
神经病学 | 599篇 |
特种医学 | 342篇 |
外科学 | 915篇 |
综合类 | 80篇 |
一般理论 | 12篇 |
预防医学 | 1012篇 |
眼科学 | 102篇 |
药学 | 582篇 |
中国医学 | 14篇 |
肿瘤学 | 516篇 |
出版年
2023年 | 35篇 |
2022年 | 62篇 |
2021年 | 129篇 |
2020年 | 70篇 |
2019年 | 136篇 |
2018年 | 172篇 |
2017年 | 123篇 |
2016年 | 143篇 |
2015年 | 174篇 |
2014年 | 228篇 |
2013年 | 326篇 |
2012年 | 480篇 |
2011年 | 536篇 |
2010年 | 369篇 |
2009年 | 257篇 |
2008年 | 521篇 |
2007年 | 582篇 |
2006年 | 609篇 |
2005年 | 520篇 |
2004年 | 492篇 |
2003年 | 486篇 |
2002年 | 517篇 |
2001年 | 133篇 |
2000年 | 119篇 |
1999年 | 107篇 |
1998年 | 88篇 |
1997年 | 88篇 |
1996年 | 63篇 |
1995年 | 71篇 |
1994年 | 51篇 |
1993年 | 35篇 |
1992年 | 39篇 |
1991年 | 37篇 |
1990年 | 40篇 |
1989年 | 31篇 |
1988年 | 42篇 |
1987年 | 37篇 |
1986年 | 37篇 |
1985年 | 34篇 |
1984年 | 26篇 |
1983年 | 30篇 |
1982年 | 24篇 |
1981年 | 27篇 |
1980年 | 26篇 |
1979年 | 29篇 |
1978年 | 19篇 |
1977年 | 26篇 |
1975年 | 20篇 |
1974年 | 28篇 |
1973年 | 18篇 |
排序方式: 共有8394条查询结果,搜索用时 15 毫秒
71.
Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces 总被引:5,自引:4,他引:1
下载免费PDF全文
![点击此处可从《Canadian Medical Association journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
72.
Ari Whiteman Alice Wang Kelly McCain Betsy Gunnels Robin Toblin James Tseryuan Lee Carolyn Bridges Laura Reynolds Bhavini Patel Murthy Judy Qualters James A. Singleton Kimberley Fox Shannon Stokley LaTreace Harris Lynn Gibbs-Scharf Neetu Abad Kathryn A. Brookmeyer Susan Farrall Cassandra Pingali Anita Patel Ruth Link-Gelles Sharoda Dasgupta Radhika Gharpure Matthew D. Ritchey Kamil. E. Barbour 《MMWR. Morbidity and mortality weekly report》2021,70(19):725
73.
Kristina Nikolova Jordan J. Steiner Judy L. Postmus Andrea Hetling Laura Johnson 《Health & social care in the community》2021,29(1):66-77
The Family Violence Option (FVO) was designed to help survivors of domestic violence (DV) more easily secure income support in the United States (U.S.), without placing them at risk of further abuse. The objective of this study is to determine whether the decision-making of advocates responsible for determining waiver recommendations under the FVO is influenced by the relationship status of DV survivors. Recursive partitioning was used to analyse data from a sample of 237 survivor risk assessments from four New Jersey counties to determine which women receive waiver recommendations and which do not. Advocates completed risk assessments for the women and were instructed to make recommendations on waivers based on their assessment. Workers’ decision-making was examined using classification and regression trees (CART) to determine what case factors made it more or less likely for survivors to be recommended waivers. The CART results were supplemented with logistic regression analyses to ensure validity. For two of three waivers, survivors who reported currently residing with their abuser or who had ended the relationship recently were less likely to receive waiver recommendations than those who had been out of the relationship for a longer period of time (OR = 0.09–0.21), even when accounting for the type and severity of DV and the impacts of the violence on survivors’ mental health. The results indicate that DV advocates’ decision-making is complicated by factors independent of survivors’ case characteristics. This can affect the safety and well-being of women attempting to leave violent relationships by affecting their access to resources. 相似文献
74.
A mouse model of AChR deficiency syndrome with a phenotype reflecting the human condition 总被引:2,自引:0,他引:2
Cossins J Webster R Maxwell S Burke G Vincent A Beeson D 《Human molecular genetics》2004,13(23):2947-2957
The two subtypes of mammalian muscle nicotinic acetylcholine receptors (AChR) are generated by the substitution of the epsilon (adult) subunit for the gamma (fetal) subunit within the AChR pentamer. Null mutations of the adult AChR epsilon-subunit gene are the most common cause of the AChR deficiency syndrome. This is a disorder of neuromuscular transmission characterized by non-progressive fatigable muscle weakness present throughout life. In contrast with the human disorder, mice with AChR epsilon-subunit null mutations die between 10 and 14 weeks of age. We generated transgenic mice that constitutively express the human AChR gamma-subunit in an AChR epsilon-subunit 'knock-out' background. These mice, in which neuromuscular transmission is mediated by fetal AChR, live well into adult life but show striking similarities to human AChR deficiency syndrome. They display fatigable muscle weakness, reduced miniature endplate potentials and endplate potentials, reduced motor endplate AChR number and altered endplate morphology. Our results illustrate how species differences in the control of ion-channel gene expression may affect disease phenotype, demonstrate that expression of adult AChR subtype is not essential for long-term survival, and suggest that in patients with AChR deficiency syndrome, up-regulation of the gamma-subunit could be a beneficial therapeutic strategy. 相似文献
75.
76.
77.
Opioids cause spasm of the sphincter of Oddi. Remifentanil is metabolized enzymatically throughout the body. Its context-sensitive half-time is 3-4 min. The effect of remifentanil on the sphincter of Oddi, is unknown. We studied, in six healthy adult volunteers, the effect of remifentanil on the flow of dye from the gall bladder into the duodenum. Control hepatobiliary imaging with 5 mCi of technetium-labeled derivatives of iminodiacetic acid was performed on each volunteer. The time from IV dye (radiopharmaceutical) injection until its appearance in the duodenum was determined by continuous scanning. Two weeks later, each volunteer received remifentanil, 0.1 microg x kg(-1) x min(-1) infused for 30 min IV before the same dose of technetium-labeled derivatives of iminodiacetic acid was injected, and for the time of their control scan plus 10 min after the injection. When the dye appeared in the duodenum, the total time from injection was compared with the control value. The time from stopping the infusion until the dye appeared in the duodenum was the "recovery time." Control scan time was 20.5+/-9.9 min (mean +/- SD; range 10-33 min). Total scan time during and after the remifentanil infusion was 50.3+/-17.3 min (range 30-81 min) (P < 0002). The recovery time was 19.8+/-12.4 min (range 5-40 min). We conclude that remifentanil delays the drainage of dye from the gall bladder into the duodenum, but the delay is shorter than that reported after other studied opioids. IMPLICATIONS: Radioactive dye was injected IV into healthy volunteers to determine the time it took for the dye to appear in the duodenum. This was repeated under the influence of a short-acting narcotic analgesic, remifentanil. Remifentanil caused a much shorter delay than previously reported after morphine or meperidine. 相似文献
78.
STUDY DESIGN: A report of three cases of pyogenic osteomyelitis of the occipitocervical junction. OBJECTIVE: To describe the conservative management of pyogenic osteomyelitis of the occipitocervical junction. SUMMARY OF BACKGROUND DATA: The therapeutic approach to inflammation of the upper cervical spine is controversial. METHODS: Pyogenic osteomyelitis of the occipitocervical junction is rare. In the orthopedic literature, only a few case reports with variable treatment methods are available. Three patients with pyogenic osteomyelitis of the occipitocervical junction were treated nonoperatively. Intravenous antibiotic therapy was begun after direct cultures or blood cultures were obtained. Early mobilization was accomplished by application of a halo vest. RESULTS: Two patients recovered by spontaneous fusion of the occipitocervical junction. Instability developed in the spine of one patient, but she refused further treatment. CONCLUSIONS: Diagnosis of osteomyelitis of the upper cervical spine is difficult. In cases with absence of neurologic symptoms or spinal abscess formation, treatment can be nonoperative. 相似文献
79.
80.
Mark C Gillies Anne Mv Brooks Stephanie Young Bill Gillies Judy M Simpson Ivan Goldberg 《Clinical & experimental ophthalmology》1999,27(1):37-44
Purpose: The aim of the present study was to investigate the safety and potential efficacy of subconjunctival interferon-α2b (IFN-α), either alone or in combination with 5-fluorouracil (5-FU), in reducing the risk of failure of glaucoma surgery. Methods: A prospective, masked randomized phase II study was undertaken in which patients received three subconjunctival injections per week for 3–4 weeks postoperatively. Three treatments were compared: (i) IFN-α (1 × 10 6 IU per dose); (ii) 5-FU (5 mg per dose); and (iii) alternating IFN-α and 5-FU (BOTH). The primary outcome measures were: (i) rate of successful control of intra-ocular pressure without further surgery; and (ii) the incidence of side effects. Results: Fifty-seven patients undergoing glaucoma surgery with an increased risk of failure were evaluated, including 23 patients (40%) undergoing trabeculectomy combined with extracapsular cataract extraction as well as other conventional high-risk groups. With 53 patients (93%) completing 2 years follow up, there was no significant difference in success rates among the three groups. Intra-ocular pressure was controlled without further surgery in 79% of patients (95% confidence interval (CI): 61, 97%) receiving IFN-α, in 89% of patients (76, 100%) receiving 5-FU and in 89% of patients (76, 100%) receiving BOTH. Side effects were similar among the three groups. Conclusions: These results are consistent with a beneficial effect of IFN-α2b given either alone or in combination with 5-FU after glaucoma filtering surgery. However, the lack of a clear and substantial benefit over conventional anti-fibrotic therapy does not support the further clinical evaluation of these treatments. 相似文献